KK
LENZ

KLP Kapitalforvaltning’s LENZ Therapeutics LENZ Stock Holding History

KLP Kapitalforvaltning’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,100
Closed -$28.4K – 2205
2026
Q1 		$28.4K Hold
3,100
– – ﹤0.01% 2149
2025
Q4 		$49.6K Hold
3,100
– – ﹤0.01% 2154
2025
Q3 		$144K Buy
3,100
+1,500
+94% +$55.2K ﹤0.01% 1939
2025
Q2 		$46.9K Hold
1,600
– – ﹤0.01% 2162
2025
Q1 		$41.1K Hold
1,600
– – ﹤0.01% 2210
2024
Q4 		$46.2K Buy
+1,600
New +$48.8K ﹤0.01% 2250

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

KLP Kapitalforvaltning's LENZ Position: Q2 2026 in Review

KLP Kapitalforvaltning sold out of LENZ Therapeutics (LENZ) in Q2 2026, closing a stake of 3,100 shares — an estimated $28.4K sold.

KLP Kapitalforvaltning first reported a position in LENZ in Q4 2024 and held it in 6 quarters. The position peaked at $144K in Q3 2025. 144 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • KLP Kapitalforvaltning reported no remaining LENZ Therapeutics position as of Q2 2026 after selling out during the quarter.
  • KLP Kapitalforvaltning sold 3,100 LENZ Therapeutics shares in Q2 2026, an estimated $28.4K.
  • KLP Kapitalforvaltning first reported a position in LENZ Therapeutics in Q4 2024 and held it in 6 quarters.
  • KLP Kapitalforvaltning's LENZ Therapeutics position peaked at $144K in Q3 2025.
  • 144 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.